{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:19:34Z","timestamp":1787019574843,"version":"build-2736575974"},"reference-count":35,"publisher":"European Respiratory Society (ERS)","issue":"5","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"funder":[{"name":"French Ministry of Health"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2021,10,2]]},"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The long-term outcomes of adult pulmonary Langerhans cell histiocytosis (PLCH), particularly survival, are largely unknown. Two earlier retrospective studies reported a high rate of mortality, which contrasts with our clinical experience.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To address this issue, all patients with newly diagnosed PLCH referred to the French national reference centre for histiocytoses between 2004 and 2018 were eligible for inclusion. The primary outcome was survival, which was defined as the time from inclusion to lung transplantation or death from any cause. Secondary outcomes included the cumulative incidences of chronic respiratory failure (CRF), pulmonary hypertension (PH), malignant diseases and extrapulmonary involvement in initially isolated PLCH. Survival was estimated using the Kaplan\u2013Meier method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>206 patients (mean age 39\u00b113\u2005years, 60% female, 95% current smokers) were prospectively followed for a median duration of 5.1\u2005years (IQR 3.2\u20137.6 years). Of these, 12 patients (6%) died. The estimated rate of survival at 10\u2005years was 93% (95% CI 89\u201397%). The cumulative incidences of CRF and\/or PH were &lt;5% at both 5 and 10\u2005years, and 58% of these patients died. 27 malignancies were observed in 23 patients. The estimated standardised incidence ratio of lung carcinoma was 17.0 (95% CI 7.45\u201338.7) compared to an age- and sex-matched French population. Eight (5.1%) of the 157 patients with isolated PLCH developed extrapulmonary involvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The long-term prognosis of PLCH is significantly more favourable than has previously been reported. Patients must be closely monitored after diagnosis to detect severe complications early.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/13993003.01017-2021","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T12:11:57Z","timestamp":1634818317000},"page":"2101017","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Long-term outcomes of adult pulmonary Langerhans cell histiocytosis: a prospective cohort"],"prefix":"10.1183","volume":"59","author":[{"given":"Amira","family":"Benattia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Bugnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"Walter-Petrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"de Margerie-Mellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Meignin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Seguin-Givelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwena\u00ebl","family":"Lorillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Chevret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdellatif","family":"Tazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"key":"2024102102423611000_59.5.2101017.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-279083"},{"key":"2024102102423611000_59.5.2101017.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1607548"},{"key":"2024102102423611000_59.5.2101017.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01190-2019"},{"key":"2024102102423611000_59.5.2101017.4","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-210125"},{"key":"2024102102423611000_59.5.2101017.5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00210711"},{"key":"2024102102423611000_59.5.2101017.6","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0249-2"},{"key":"2024102102423611000_59.5.2101017.7","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.96.09102002"},{"key":"2024102102423611000_59.5.2101017.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012087"},{"key":"2024102102423611000_59.5.2101017.9","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1378\/chest.111.4.1142-a","article-title":"Advanced pulmonary histiocytosis X is associated with severe pulmonary hypertension","volume":"111","author":"Harari","year":"1997","journal-title":"Chest"},{"key":"2024102102423611000_59.5.2101017.10","first-page":"460","article-title":"Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation","volume":"16","author":"Harari","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"2024102102423611000_59.5.2101017.11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejim.2015.04.001","article-title":"Pulmonary Langerhans cell histiocytosis: a comprehensive analysis of 40 patients and literature review","volume":"26","author":"Elia","year":"2015","journal-title":"Eur J Intern Med"},{"key":"2024102102423611000_59.5.2101017.12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejim.2017.11.011","article-title":"Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis","volume":"51","author":"Montefusco","year":"2018","journal-title":"Eur J Intern Med"},{"key":"2024102102423611000_59.5.2101017.13","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930201)71:3<865::AID-CNCR2820710334>3.0.CO;2-0"},{"key":"2024102102423611000_59.5.2101017.14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.101.6.1610"},{"key":"2024102102423611000_59.5.2101017.15","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00007509"},{"key":"2024102102423611000_59.5.2101017.16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13023-017-0651-z","article-title":"Vinblastine chemotherapy in adult patients with Langerhans cell histiocytosis: a multicenter retrospective study","volume":"12","author":"Tazi","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"2024102102423611000_59.5.2101017.17","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.2000.16a01.x"},{"key":"2024102102423611000_59.5.2101017.18","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00038503"},{"key":"2024102102423611000_59.5.2101017.19","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01032-2015"},{"key":"2024102102423611000_59.5.2101017.20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02148-2018"},{"key":"2024102102423611000_59.5.2101017.21","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djg052"},{"key":"2024102102423611000_59.5.2101017.22","unstructured":"Binder-Foucard F , Belot A , Delafosse P , et al. Estimation nationale de l\u2019incidence et de la mortalit\u00e9 par cancer en France entre 1980 et 2012. \u00c9tude \u00e0 partir des registres des cancers du r\u00e9seau Francim. Partie 1 \u2013 Tumeurs solides [National estimates of the incidence and mortality from cancer in France between 1980 and 2012. A study based on Francim network of cancer registries. Part 1 \u2013 Solid Tumors]. Saint-Maurice, Institut de Veille Sanitaire, 2013."},{"key":"2024102102423611000_59.5.2101017.23","doi-asserted-by":"publisher","DOI":"10.4065\/79.10.1269"},{"key":"2024102102423611000_59.5.2101017.24","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2490"},{"key":"2024102102423611000_59.5.2101017.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2006.00299.x"},{"key":"2024102102423611000_59.5.2101017.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11169.x"},{"key":"2024102102423611000_59.5.2101017.27","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcv185"},{"key":"2024102102423611000_59.5.2101017.28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/bjh.14818","article-title":"Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long-term outcomes","volume":"182","author":"Goyal","year":"2018","journal-title":"Br J Haematol"},{"key":"2024102102423611000_59.5.2101017.29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cam4.1844","article-title":"Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies","volume":"8","author":"Ma","year":"2019","journal-title":"Cancer Med"},{"key":"2024102102423611000_59.5.2101017.30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-761718"},{"key":"2024102102423611000_59.5.2101017.31","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70211-4"},{"key":"2024102102423611000_59.5.2101017.32","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21044"},{"key":"2024102102423611000_59.5.2101017.33","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1111\/jdv.16850","article-title":"Langerhans cell histiocytosis associated with chronic myelomonocytic leukaemia both harbouring the same BRAF V600E mutation: efficacy of vemurafenib","volume":"35","author":"Konstantinou","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024102102423611000_59.5.2101017.34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.lungcan.2013.03.001","article-title":"Major changes in lung cancer over the last ten years in France: the KBP-CPHG studies","volume":"81","author":"Locher","year":"2013","journal-title":"Lung Cancer"},{"key":"2024102102423611000_59.5.2101017.35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2213-2600(18)30284-4","article-title":"Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis","volume":"6","author":"Duruisseaux","year":"2018","journal-title":"Lancet Respir Med"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01017-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:48:21Z","timestamp":1740358101000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01017-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,26]]},"published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1183\/13993003.01017-2021"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01017-2021","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]}}}